Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Century Therapeutics (IPSC) Short term Debt (2022 - 2025)

Historic Short term Debt for Century Therapeutics (IPSC) over the last 3 years, with Q3 2025 value amounting to $8.3 million.

  • Century Therapeutics' Short term Debt changed N/A to $8.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.3 million, marking a year-over-year change of. This contributed to the annual value of $6.5 million for FY2022, which is N/A changed from last year.
  • Latest data reveals that Century Therapeutics reported Short term Debt of $8.3 million as of Q3 2025.
  • In the past 5 years, Century Therapeutics' Short term Debt registered a high of $10.3 million during Q1 2023, and its lowest value of $1.6 million during Q2 2022.
  • In the last 3 years, Century Therapeutics' Short term Debt had a median value of $6.5 million in 2022 and averaged $6.2 million.